Medison to distribute ColorMark in Far East:
This article was originally published in Clinica
Executive Summary
Medison, of South Korea, is to have exclusive distribution rights to EchoCath's ColorMark Systems in the Far East. The US firm's product is a needle visualisation system for ultrasound-guided tissue biopsies. Medison will buy a minimum, undisclosed, number of the systems over the next 12 months. The companies also agreed to collaborate on certain ultrasound technologies for future products. Medison is to use the ColorMark technology with its Voluson product, which it claims is the world's only real-time 3D digital ultrasound imaging system, and its Trident digital colour Doppler system.
You may also be interested in...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.